Systematic brain magnetic resonance imaging and safety evaluation of non-invasive ultrasound therapy for patients with severe symptomatic aortic valve stenosis
Danijela Trifunovic-Zamaklar, Miloš Velinović, Nataša Kovačević-Kostić, Emmanuel Messas, Danijela Trifunovic-Zamaklar, Miloš Velinović, Nataša Kovačević-Kostić, Emmanuel Messas
No abstract availableKeywords: MRI; aortic stenosis; calcification; non-invasive ultrasound therapy; stroke.
Conflict of interest statement
Conflict of interest: D.T.Z., M.V., and N.K.K. were investigators of the study. D.T.Z. reports honoraria for lectures from Astra Zeneca, Boehringer Ingelheim, Pfizer, Hemofarm, and Amicus and received support to attend meetings from Boehringer, participates in DSMBs/advisory boards for Boehringer, and is the president of the Serbian Society of Echocardiography. E.M. is a co-founder and scientific advisory board member of Cardiawave and holds shares in the company and subsequently has royalties/licenses, receives consulting fees, support to attend meetings, and is involved in patents. All other authors declare having nothing to disclose.
Figures
References
- Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs Jet al. . 2021 ESC/EACTS guidelines for the management of valvular heart disease. EuroIntervention 2022;17:e1126–e96.
- Durko AP, Osnabrugge RL, Van Mieghem NM, Milojevic M, Mylotte D, Nkomo VTet al. . Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J 2018;39:2635–42.
- Messas E, Ijsselmuiden A, Goudot G, Vlieger S, Zarka S, Puymirat Eet al. . Feasibility and performance of noninvasive ultrasound therapy in patients with severe symptomatic aortic valve stenosis: A first-in-human study. Circulation 2021;143:968–70.
- Pérez-Camargo D, Travieso A, Carnero-Alcázar M, Taramasso M, Cobiella-Carnicer J, Maroto-Castellanos LC. Neurological outcomes of transcatheter aortic valve implantation with or without cerebral embolic protection devices: a meta-analysis. J Stroke Cerebrovasc Dis 2022;31:106605.
- Nazif TM, Moses J, Sharma R, Dhoble A, Rovin J, Brown Det al. . Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement: REFLECT II. JACC Cardiovasc Interv 2021;14:515–27.
Source: PubMed